Sigyn Therapeutics, Inc. (SIGY) SEC Filings — 2024
15 SEC filings for Sigyn Therapeutics, Inc. (SIGY) in 2024.
Filings
- Sigyn Therapeutics Files 10-Q for Q3 2024 — 10-Q · Nov 19, 2024
- Sigyn Therapeutics Files 8-K/A Amendment on Equity Sales — 8-K/A · Oct 16, 2024
- Sigyn Therapeutics Sells Shares for $100 — 8-K · Oct 7, 2024
- Sigyn Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 19, 2024
- Sigyn Therapeutics Announces $5M Stock Repurchase Program — 8-K · Jun 6, 2024
- Sigyn Therapeutics Changes Principal Executive Offices — 8-K · May 15, 2024
- Sigyn Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- Sigyn Therapeutics Enters Material Definitive Agreement — 8-K · Apr 16, 2024
- Sigyn Therapeutics Files S-1/A Amendment — S-1/A · Apr 10, 2024
- Sigyn Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 20, 2024
- Brio Capital Amends Sigyn Therapeutics Stake (SC 13G/A) — SC 13G/A · Feb 8, 2024
- Sigyn Therapeutics Updates Principal Office, Phone Number — 8-K · Jan 31, 2024
- Sigyn Therapeutics Relocates HQ to Beverly Hills — 8-K · Jan 30, 2024
- Sigyn Therapeutics Files 8-K on Material Agreement; Details Undisclosed — 8-K · Jan 11, 2024
- Sigyn Therapeutics Relocates HQ to Beverly Hills — 8-K · Jan 8, 2024